# Cayman Pharma s.r.o. – FDA Inspection, Jan 30, 2020

Source: https://www.keypedia.com/records/fda_inspections/cayman-pharma-sro/30d542f5-0ae2-4fcb-8c39-5e4de0aaea08
Source feed: FDA_Inspections

> FDA inspection 1132387 of Cayman Pharma s.r.o., January 30, 2020. Classification: Voluntary Action Indicated (VAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1132387
- Company Name: Cayman Pharma s.r.o.
- Inspection Date: 2020-01-30
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1271067 - 2022-07-28
- FDA Inspection 1011579 - 2017-03-30
- FDA Inspection 876913 - 2014-03-27
- FDA Inspection 722239 - 2011-03-17

Company: https://www.keypedia.com/companies/cayman-pharma-sro/4048320f-8569-4c0e-99d0-8b8191b5b5b0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c